Reports: The Rise of Companion Apps: A $20B Opportunity for Pharma by 2029 report

The leading digital health reports on app economy.

The Rise of Companion Apps: A $20B Opportunity for Pharma by 2029

Published: 29-07-2025

Companion solutions are digital tools, primarily mobile apps, software platforms, or sensor-integrated systems designed to support the use of specific pharmaceutical drugs or medical devices. These solutions provide a range of patient support services such as symptom tracking, medication reminders, educational content, adherence monitoring, telehealth integration, and, in some cases, drug or device ordering. Unlike Learn more…

Excellent content, just as we expected!

“I wholeheartedly agree with all of the quotes I read, and really appreciate the way the report highlights the problems of current apps. This will be great supporting material for us when presenting our idea to investors. I also see us using the information for fine-tuning our own approach to different markets.”

- Mikael Rinnetmäki, CEO Sensotrend

“The Diabetes App Market Report by research2guidance is comprehensive and far reaching. It allows the reader to get a real feel for the state of the Diabetes App Market in Europe and provides some excellent strategic guidance. It is a really valuable piece of market intelligence about the Diabetes mHealth market in Europe, in fact the best I have read on this specific issue to date.”

- Petra Wilson, President IDF

“On the basis of your report we gained helpful insights about the needs, expectations, chances and fears regarding market players.”

- Mihaela Stipic Marketing & PR Manager, All About Apps

“The report was very useful and helped me to analyze not only the actual market but future trends.”

- Florencia Rolandi CEO, TuMedicinaDigital